COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022

被引：562

作者：

Kislaya, Irina ^{[1
,2
]}

Machado, Ausenda ^{[1
,2
]}

Magalhaes, Sarah

Rodrigues, Ana Paula

Franco, Rafael

Leitek, Pedro Pinto ^{[3
,4
]}

Dias, Carlos Matias ^{[1
,2
]}

Nunes, Baltazar ^{[1
,2
]}

机构：

[1] Inst Nacl Sailde Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal

[2] Univ NOVA Lisboa, Ctr Invest Saude Publ, Escola Nacl Saude Publ, Lisbon, Portugal

[3] Serv Partilhados Minist Saude, Lisbon, Portugal

[4] Direcao Servi Informacao & Analise, Direcao Geral Saude, Lisbon, Portugal

来源：

EUROSURVEILLANCE | 2022年 / 27卷 / 37期

关键词：

D O I：

10.2807/1560-7917.ES.2022.27.37.2200697

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in elderly people in Portugal between May and July 2022. In 2 80 year -olds, the second booster dose VE was 81% (95% CI: 75-85) and 82% (95% CI: 77-85), respectively, against COVID-19-related hospitalisation and death. The first booster dose VE was 63% (95% CI: 55-70) in 2 80 year -olds and 74% (95% CI: 66-80) in 60-79 year-olds against hospitalisation, and 63% (95% CI: 57-69) and 65% (95% CI: 54-74) against death.

引用

页数：6

共 41 条

[1] Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
Zeng, Ting
Lu, Yaoqin
Zhao, Yanji
Guo, Zihao
Sun, Shengzhi
Teng, Zhidong
Tian, Maozai
Wang, Jun
Li, Shulin
Fan, Xucheng
Wang, Weiming
Cai, Yongli
Liao, Gengze
Liang, Xiao
He, Daihai
Wang, Kai
Zhao, Shi
RESPIRATORY RESEARCH, 2023, 24 (01)
[2] Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
Ting Zeng
Yaoqin Lu
Yanji Zhao
Zihao Guo
Shengzhi Sun
Zhidong Teng
Maozai Tian
Jun Wang
Shulin Li
Xucheng Fan
Weiming Wang
Yongli Cai
Gengze Liao
Xiao Liang
Daihai He
Kai Wang
Shi Zhao
Respiratory Research, 24
[3] Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort
Itamochi, Masae
Yazawa, Shunsuke
Inasaki, Noriko
Saga, Yumiko
Yamazaki, Emiko
Shimada, Takahisa
Tamura, Kosuke
Maenishi, Emi
Isobe, Junko
Nakamura, Masahiko
Takaoka, Misuzu
Sasajima, Hitoshi
Kawashiri, Chikako
Tani, Hideki
Oishi, Kazunori
VACCINE, 2023, 41 (13) : 2234 - 2242
[4] Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022
Petrie, Joshua G.
King, Jennifer P.
McClure, David L.
Rolfes, Melissa A.
Meece, Jennifer K.
Pattinson, David
Neumann, Gabriele
Kawaoka, Yoshihiro
Belongia, Edward A.
McLean, Huong Q.
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (03)
[5] Effectiveness of A Fourth Dose of COVID-19 mRNA Vaccine in the Elderly Population During the Omicron BA.2 and BA.5 Circulation: A Nationwide Cohort Study in Korea (K-COVE)
Park, Seon Kyeong
Choe, Young June
Jang, Eun Jung
Kim, Ryu Kyung
Lim, Do-Sang
Yi, Seonju
Lee, Sangwon
Kwon, Geun-Yong
Shin, Jee Yeon
Choi, Sang-Yoon
Jeong, Mi Jin
Park, Young-Joon
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (03):
[6] Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
Link-Gelles, Ruth
Levy, Matthew E.
Natarajan, Karthik
Reese, Sarah E.
Naleway, Allison L.
Grannis, Shaun J.
Klein, Nicola P.
DeSilva, Malini B.
Ong, Toan C.
Gaglani, Manjusha
Hartmann, Emily
Dickerson, Monica
Stenehjem, Edward
Kharbanda, Anupam B.
Han, Jungmi
Spark, Talia L.
Irving, Stephanie A.
Dixon, Brian E.
Zerbo, Ousseny
McEvoy, Charlene E.
Rao, Suchitra
Raiyani, Chandni
Sloan-Aagard, Chantel
Patel, Palak
Dascomb, Kristin
Uhlemann, Anne-Catrin
Dunne, Margaret M.
Fadel, William F.
Lewis, Ned
Barron, Michelle A.
Murthy, Kempapura
Nanez, Juan
Griggs, Eric P.
Grisel, Nancy
Annavajhala, Medini K.
Akinseye, Akintunde
Valvi, Nimish R.
Goddard, Kristin
Mamawala, Mufaddal
Arndorfer, Julie
Yang, Duck-Hye
Embi, Peter J.
Fireman, Bruce
Ball, Sarah W.
Tenforde, Mark W.
JAMA NETWORK OPEN, 2023, 6 (03) : E232598
[7] Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants
Maltezou, Helena C.
Gamaletsou, Maria N.
Giannouchos, Theodoros, V
Koukou, Dimitra-Maria
Sourri, Flora
Karapanou, Amalia
Lemonakis, Nikolaos
Souliotis, Kyriakos
Lourida, Athanasia
Panagopoulos, Periklis
Hatzigeorgiou, Dimitrios
Sipsas, Nikolaos, V
VACCINE, 2024, 42 (17) : 3693 - 3698
[8] Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents-19 States, March 29-July 25, 2022
McConeghy, Kevin W.
White, Elizabeth M.
Blackman, Carolyn
Santostefano, Christopher M.
Lee, Yoojin
Rudolph, James L.
Canaday, David
Zullo, Andrew R.
Jernigan, John A.
Pilishvili, Tamara
Mor, Vincent
Gravenstein, Stefan
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (39): : 1235 - 1238
[9] Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1-and BA.2-Predominant Periods in Japan: The VENUS Study
Mimura, Wataru
Ishiguro, Chieko
Maeda, Megumi
Murata, Fumiko
Fukuda, Haruhisa
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
[10] Effectiveness of mRNA-1273 bivalent (original and omicron BA.4/BA.5) COVID-19 vaccine against hospitalizations for COVID-19, medically attended SARS-CoV-2 infections, and COVID-19 hospital deaths in the United States
Tseng, Hung Fu
Ackerson, Bradley K.
Sy, Lina S.
Tubert, Julia E.
Luo, Yi
Qiu, Sijia
Bruxvoort, Katia J.
Lee, Gina S.
Ku, Jennifer H.
Florea, Ana
Takhar, Harpreet S.
Zhou, Cindy Ke
Esposito, Daina
Chavers, Scott
Talarico, Carla A.
Qian, Lei
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 609 - 609

← 1 2 3 4 5 →